About Redoxis
Redoxis is a leading contract research organization specializing in preclinical drug development services. With a strong focus on inflammatory and autoimmune diseases, we provide high-quality in vitro and in vivo studies to support early-stage drug discovery and efficacy evaluation.
At Redoxis, we offer a broad range of expertise in different drug modalities, including small molecules, biologics, cell and gene therapies, and mRNA-based treatments. Our state-of-the-art laboratory facilities and dedicated team enable us to deliver reliable and reproducible data to accelerate the development of innovative therapeutics.
With a commitment to scientific excellence and customer collaboration, Redoxis partners with biotech and pharmaceutical companies worldwide. Our goal is to advance the development of next-generation treatments by providing reliable preclinical data and expert guidance throughout the drug discovery process.
Contact us to learn more about how Redoxis can support your research and drug development needs.
